Home Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents
 

Keywords :   


Kyle Bass Loses Round 1 of IPR Attack Against Pharma/Biotech Patents

2015-08-29 06:06:18| Biotech - Topix.net

On August 24, 2015, the Patent Trial and Appeal Board declined institution of two petitions filed by Coalition For Affordable Drugs for Inter Partes Reviews of Acorda's patents covering Ampyra, a billion-dollar drug for treating multiple sclerosis. The Petitioner, Coalition For Affordable Drugs, is a wholly owned subsidiary of a hedge fund managed by Kyle Bass, which appears to have little to do with the life science and drug industry other than filing IPR petitions against patents owned by pharmaceutical and biotechnology companies.

Tags: round attack bass patents

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
22.11SHIMANO BT Master 11AP)
22.11
22.11
22.11GOLDWIN
22.11Qi10 TOUR 5W WF
22.11
22.11GX HR
22.11 GEORGIA
More »